학술논문

81TiP NVL-655, a selective anaplastic lymphoma kinase (ALK) inhibitor, in patients with advanced ALK-positive solid tumors: The phase I/II ALKOVE-1 study
Document Type
Abstract
Source
In Journal of Thoracic Oncology April 2023 18(4) Supplement:S86-S87
Subject
Language
ISSN
1556-0864